Archive for the ‘Lyme’ Category

Cellular Blueprint of MS Lesions

https://www.nih.gov/news-events/news-releases/nih-scientists-build-cellular-blueprint-multiple-sclerosis-lesions

Friday, September 10, 2021

NIH scientists build a cellular blueprint of multiple sclerosis lesions

Study lays the groundwork for potential new therapies for progressive multiple sclerosis.

Chronic lesions with inflamed rims, or “smoldering” plaques, in the brains of people with multiple sclerosis (MS) have been linked to more aggressive and disabling forms of the disease. Using brain tissue from humans, researchers at the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS) built a detailed cellular map of chronic MS lesions, identifying genes that play a critical role in lesion repair and revealing potential new therapeutic targets for progressive MS. The study was published in Nature.

“We identified a set of cells that appear to be driving some of the chronic inflammation seen in progressive MS,” said Daniel Reich, M.D., Ph.D., senior investigator at NINDS. “These results give us a way to test new therapies that might speed up the brain’s healing process and prevent brain damage that occurs over time.”

Chronic active lesions are characterized by a slow, expanding rim of immune cells called microglia. Microglia normally help protect the brain, but in MS and other neurodegenerative diseases, they can become overactive and secrete toxic molecules that damage nerve cells. Other cells found at the edge of the lesions, such as astrocytes and lymphocytes, may also contribute to ongoing tissue damage. Prior studies suggest that microglia are the main culprits behind lesion expansion, but the exact types of cells found near lesions and their biological mechanisms are elusive.

To better understand MS lesions, Dr. Reich and his colleagues used single-cell RNA sequencing, a powerful technique which enables researchers to catalog gene activity patterns in individual cells, to examine post-mortem brain tissue of five MS patients and three healthy controls. Samples were provided by the Netherlands Brain Bank, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands, and the NINDS Neuroimmunology Clinic.

“Single-cell RNA sequencing technology allows us to do a much deeper dive into the types of cells present in MS lesions,” said Dr. Reich.

By analyzing the gene activity profiles of over 66,000 cells from human brain tissue, researchers created the first comprehensive map of cell types involved in chronic lesions, as well as their gene expression patterns and interactions.

Dr. Reich’s team found a great diversity of cell types in the tissue surrounding chronic active lesions compared to normal tissue, and a high proportion of immune cells and astrocytes at the active edges of those lesions. Microglia comprised 25% of all immune cells present at the lesion edges.

“Our dataset is very rich. The beauty of having such a detailed map is that now we have a better understanding of the entire network of cells involved in smoldering inflammation,” said Martina Absinta, M.D., Ph.D., a former post-doctoral fellow in Dr. Reich’s lab and current adjunct assistant professor at Johns Hopkins University, Baltimore, who led the study.

More detailed analyses revealed that the gene for complement component 1q (C1q), an important and evolutionarily ancient protein of the immune system, was expressed mainly by a subgroup of microglia responsible for driving inflammation, suggesting that it may contribute to lesion progression.

To determine the function of C1q, researchers knocked out the gene in the microglia of mouse models of MS and examined the brain tissue for signs of neuroinflammation. In mice lacking microglial C1q, they found significantly decreased tissue inflammation compared to control animals. Additionally, in another group of animals, blocking C1q reduced iron-containing microglia, revealing a potential new therapeutic avenue to treat chronic brain inflammation in MS and related neurodegenerative diseases.

According to the authors, it’s possible that targeting C1q in human microglia could halt MS lesions in their tracks.

In MS, the immune system attacks myelin, a protective layer that forms around nerve cells in the brain and spinal cord, leading to vision loss, muscle weakness, problems with balance and coordination, fatigue, numbness, and other debilitating symptoms. A subset of people develop progressive MS, resulting in extensive brain tissue damage and disability. Anti-inflammatory medications help patients manage their symptoms by dampening the responses of immune cells in the blood and lymph nodes. But treatments are not as effective for patients with chronic lesions who experience ongoing brain tissue inflammation.

“We have terrific therapies that block new inflammation but nothing to stop the inflammation that’s already there,” said Dr. Reich. “In order to make strides in developing new therapies for progressive MS, we’re going to need to pick apart the cellular and molecular mechanisms one by one.”

In 2019, Dr. Reich and his team reported that damaging, chronic active lesions may be a hallmark of progressive MS. The current study identifies microglia and C1q as promising targets for progressive MS and supports the use of chronically inflamed rim lesions as an MRI biomarker for disease progression.

There is no cure for MS, and no therapies that directly treat chronic active lesions. By gaining a deeper understanding of lesion features, this study may help pave the way toward early clinical trials to test new therapies for this aspect of the disease.

This study was supported in part by the Intramural Research Program at the NINDS.

NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

Open Letter to Governors and Congressmen in Lyme Endemic Areas

https://www.change.org/p/the-us-senate-calling-for-a-congressional-investigation-of-the-cdc-idsa-and-aldf

Open letter to Governors and Congressmen in Lyme endemic areas

Carl Tuttle

Hudson, NH, United States

Sep 9, 2021 — 

Please see the latest email below sent to the Chair of the NH Lyme Disease Study Commission…

———- Original Message ———-

From: CARL TUTTLE runagain@comcast.net
To: Leah Cushman <Leah.Cushman@leg.state.nh.us>, Jerry Knirk Jerry.Knirk@leg.state.nh.us
Cc: All members of the NH Lyme Disease Study Commission
Date: 09/08/2021 9:10 AM
Subject: Dr. Paul H. Duray Pathology Fellowship; Open letter to  Governors and Congressmen in Lyme endemic areas

To Members of the Lyme Disease Study Commission,Autopsy results are painting an entirely different picture of disease from what our public health officials have been propagating; “hard to catch and easily treated”

This deception, (for the sake of a vaccine) has caused untold pain and suffering as persistent infection after extensive antibiotic treatment has been denied for three decades. A chronic relapsing seronegative disease did not fit the vaccine model.

Please see the following Open Letter from Tom Grier, Pathology Study Coordinator from the Dr. Paul H. Duray Pathology Fellowship:

A copy of this letter can be downloaded from my personal Dropbox storage area:
https://www.dropbox.com/s/gre4ej07f2p3jd5/congress4pageLTR.pdf?dl=0

_______________________________________

Dr. Paul H. Duray Pathology Fellowship
Thomas M. Grier MS (Pathology Study Coordinator)
902 Grand View Ave
Duluth MN 55812-1146
218-216-5670
donatebrain@gmail.com

Open letter to  Governors and Congressmen in Lyme endemic areas

Why Lyme disease is so confusing, and what the medical experts got wrong

  • Today’s medical perspective of Lyme disease is entirely based on serology (blood tests) and not pathology. (*Pathology includes brain and heart autopsies, culturing, and tissue staining – see photo section.)
  • Lyme disease (LD) blood-tests are fundamentally flawed. *(explanation follows)
  • The authorities that support current diagnostic and treatment guidelines for Lyme disease often have financial conflicts of interests.
  • Since 1975, many so called “FACTS” about Lyme disease have been proven wrong, but medical institutions won’t ever admit their mistakes.
Untrue facts that the public and doctors were told by the IDSA, CDC, NIH, Yale, Harvard, SUNY, and Mayo Clinic that were never true and proven wrong by many studies, and never publicly corrected.
  • Only one tick species (Ixodes damminii) transmits Lyme disease
  • Lyme disease does not cross from infected mother to fetus
  • Lyme disease is not an intracellular disease (can invade inside human cells)
  • Lyme disease stays in the blood and does not enter the human brain.
  • The Lyme disease ELISA tests ate 99% accurate
  • Lyme disease does not persist after 28 days of antibiotic treatment
  • Lyme disease is mainly and arthritic disease
  • Lyme disease is mainly found in the NE USA
  • Lymerix Lyme vaccine had no side effects and was pulled because of anti-vax hysteria.

All these so called “Lyme-Facts” are wrong. They were never true. These published  untruths are a result of major medical institutions relying almost entirely on their own Lyme-Disease-Blood-Tests to determine both diagnosis, and successful treatment. Our own medical experts have continually ignored  overwhelming pathology evidence that proves their assumptions and observations about Lyme have been fundamentally flawed. Their reputations mean more than patient’s lives!

What’s wrong with the Lyme disease blood Tests?

The LD tests that we have used for 35 years are made with B-31 lab-strain of Borrelia burgdorferi . B-31 Lab-strain is not found in ticks, humans or animal reservoirs. It is a manmade analog of a strain found in nature stripped of two chromosomes. The proteins expressed on B-31 Lab Strain Borrelia, never change in culture. In nature these bacterial surface proteins that our immune system attack are constantly changing. B-31 Lab Strain is a cheap way to make consistently bad Lyme-disease blood-tests.

In independent comparison testing: B-31 tests, overall even under the best conditions, are  only 50 % accurate: So, Lyme disease testing has always been like  flipping a coin.

To be blunt, the LD blood-tests using B-31 strain are flawed by design.

  • LD blood tests at best, can only detect one species of Lyme (There are 11 pathogenic species) The blood tests only detect the first isolate of Lyme disease from 1982. The original isolate is a Genus-species we named Borrelia burgdorferi. But since 1982 we have discovered a dozen new Borrelia species that cause human disease. (*See partial table)

Borreilia burgdorferi lato species table
https://www.dropbox.com/s/zgl2pxl1qcl2lwc/Bb%20species.png?dl=0

-The Deer-Ticks also carry Borrelia myamotoi , a Tick-Born Relapsing Fever (TBRFs) that is transmitted from the Deer-Tick in just 20 minutes. So, continuing to tell patients that a deer-tick must be attached for 24-48 hours is irresponsible

Borrelia myamotoi has an affinity for the human brain. The Borrelia myamotoi pathogen is a serious threat in the America.  It is carried by the same ticks as Lyme disease, it has the ability to enter the human brain undetected until brain autopsies are performed. Lyme disease blood tests cannot detect this species of Borrelia.

(See the Borrelia  myamotoi biofilms found embedded in Alzheimer’s amyloid plaques)

-Borrelia species including burgdorferi and B. myamotoi penetrate blood vessels quickly and easily. They are highly motile so within hours of a tick bite, the bacteria can enter any human organ, including the brain and the heart.

Once the Lyme spirochete has entered a blood vessel wall, an organ or has gone inside a human cell: it is harder to detect.

Our tax-dollars pays for the creation of CDC Lyme-disease blood tests. These tests are patented, but the patents are put in the names of CDC officers.

I will show that these tests were never better than 50 % accurate.

The CDC is now funding a new group of Lyme tests. I am asking: Who will own those fresh patents?

Borrelia spirochetes inside hippocampal neurons in Alzheimer’s disease
https://www.dropbox.com/s/5gyqcjn3wp9s93g/Nerve%20Cell.jpg?dl=0

Please stop listening to the Lyme disease experts that misled us since 1975 and start looking at the pathology evidence that proves them wrong.

  • Request human brain pathology studies without CDC or previously mentioned institutions involvement.
  • Create an independent panel of researchers to review the accuracy of Lyme disease IDSA facts
  • Allow doctors to treat beyond the IDSA guideline without harassment or loss of their medical license.
  • Support the investigation to look into the weaponization of Ticks and Tick-Borne-Diseases

Thank You,

100+ References and 100+ Photos available proving persistence post antibiotic treatment.

Sincerely,

Thomas M. Grier
(Director of pathology studies at the Dr. Paul H. Duray Pathology Fellowship)

Brain Autopsy Neuroborreliosis Patient from MN
https://www.dropbox.com/s/qsx6eni1icq4n0w/Brain%20Autopsy%20Neuroborreliosis%20Patient%20from%20MN.png?dl=0

_________________________________________________

WHAT IS PATHOLOGY?
https://www.mcgill.ca/pathology/about/definition

“Pathology is a branch of medical science that involves the study and diagnosis of disease through the examination of surgically removed organs, tissues (biopsy samples), bodily fluids, and in some cases the whole body (autopsy).”

Carl Tuttle
Hudson, NH

Cc:
-Pistis LLC, Hired by HHS
-Bennett Nemser, Senior Program Officer, the Cohen Lyme and Tickborne Disease Initiative
-Holiday Goodreau and Linden Hu, M.D. Co-chairs of the Tick-borne Disease Working Group
-Governor Chris Sununu

A Tick Bite at Age 6, Followed by More Than 40 Years of Health Problems

https://www.lymedisease.org/edmisten-tbdwg-lyme-comments/

A tick bite at age 6, followed by more than 40 years of health problems

Marta Edmisten gave the following as public comments at the August 26 meeting of the federal Tick-Borne Disease Working Group.

Good morning, my name is Marta Edmisten. I am here today to talk about the impact tick-borne disease has had on me.

I had my first known tick bite around age 6, in 1980. I found a bump behind my right earlobe. I vividly remember my mom dropping the wriggling tick into a medicine dosing cup full of rubbing alcohol, which immediately turned red.

That was two years before Borrelia burgdorferi was officially identified and even more years before testing was available.

I am now 47 and currently live with two strains of babesiosis, two strains of Bartonella, active Lyme disease, as well as tick-borne relapsing fever.

My testing is recent and not “borderline.” This is after over five years of treatment. I am here to tell everyone that the adage that tick-borne disease is hard to get and easy to get rid of is simply not true for so many of us.

Within a year of my first tick bite, I developed endocrine issues so worrisome that I was followed by the head of endocrinology at DC’s Children’s Hospital for fourteen months. No cause was ever discovered.

Problems in school

By age 8, I suddenly developed attention and reading issues after having flawless testing results in kindergarten. I also struggled with a sudden onset of allergies and asthma. My joints would swell out of nowhere and ache. I was screened for juvenile rheumatoid arthritis. The results were negative.

By middle school I suffered from anxiety, depression, depersonalization, suicidal ideation, insomnia, memory issues, and confusion.

I was officially diagnosed with ADHD and dyslexia after getting less that 400 on the SATs. My GPA at the time was stellar. I worked really hard.

I got my second known tick bite in Rhode Island while I was in college. I had a bull’s-eye rash all over my neck. I was told it was a spider bite and sent home.

I was diagnosed with  SMI—serious mental illness—soon thereafter. For over two decades, I saw preeminent psychiatrists in Boston and New York City. I took all the pills–nothing worked. I was hospitalized multiple times. I voluntarily underwent electroconvulsive therapy (ECT) treatments.

By the time I was 36, my arms and legs often twitched uncontrollably and soon fatigue and pain made running my successful business impossible. At 40, my vision was so poor I was unable to read, walking was impossible, and I became incontinent. Multiple autoimmune diseases were suspected. I was finally tested for Lyme disease and co-infections in 2016. I started treatment soon thereafter.

I am no longer on psychiatric medications, just things to help me sleep. Physically, I am better, but I’m still extremely disabled. Just last fall, I spent months not recognizing my home or remembering that my closest friend had passed away over a year earlier.

I look perfectly normal — as long as I am seated. I live with extreme mobility issues, drenching sweats, intermittent fevers, neuropathy, immune dysfunction, pain that often makes sleep impossible, and cognitive issues that make my dream of becoming a social worker out of reach at this time. There are so many people with my story.  Please believe us.  Please help us.

Marta Edmisten lives in Maryland.

______________________

For more:

What’s Behind This Epidemic of Chronic, Inflammatory Conditions?

https://www.lymedisease.org/kinderlehrer-epigenetics/

What’s behind this epidemic of chronic, inflammatory conditions?

by Daniel A. Kinderlehrer MD

I have witnessed many changes in the over 40 years I’ve been a doctor, including epidemic rises in multiple medical conditions.

I’m not talking about the present pandemic, nor am I referring to the opioid crisis, another devastating epidemic that has taken the lives of over 500,000 Americans. I’m talking about chronic conditions that cause a slow burn and sometimes kill.

Lyme disease is but one example.

But think how things have changed since the beginning of the previous century: heart disease was barely on the radar in 1900, but for over 50 years it has been the number one cause of death in the U.S.1

A whopping 69% of Americans are now overweight, with 36.5% obese,2 directly contributing to the skyrocketing incidence of adult-onset diabetes mellitus.3 When I was in training in the 1970s, I never saw a patient with AODM who was under 40 years old. Now, it is being diagnosed in children.

And then there are the dramatic increases in autism spectrum disorder,4 attention deficit hyperactivity disorder (ADHD),5 autoimmune conditions,6 some types of cancer7 and food allergies.8

Food sensitivities, mental health

Twenty-five years ago, when I had a large environmental medicine practice, most of my patients with food sensitivities reacted to one or more of a half dozen foods: milk, corn, eggs, wheat, citrus, or sugar/yeast. It was easy to put patients on an elimination diet: fish, lamb, vegetables, legumes, potatoes and rice. Now people react to avocados, rice, and anything under the sun.

And, of course, there’s the rise in mental health disorders. Even before the Covid pandemic, the World Health Organization predicted that depression would become the leading cause of death globally.9

According to the CDC, in 2019, 19% of Americans suffered from depression and 7% were moderately to severely affected.10 Among adults, suicidal ideation is increasing. Suicide has become the second leading cause of death in children and adolescents ages 13 to 19—and the leading cause of death among 13 year-olds.11 (Among all Americans, it is the tenth leading cause of death.11)

The role of epigenetics

There are a host of factors that determine the how, where and why illness occurs. These include genetic proclivity, lifestyle, trauma, diet, exposures to microbes and toxins. But here is what is further catapulting these seemingly disparate epidemics: a change in the human condition that we now understand as epigenetics.

While it takes millennia of natural selection to change our genes, specific proteins that turn genes on and off can alter gene expression in a single generation. Epigenetics explains how a change in expression of genes can be passed from one generation to the next without actually changing the DNA. There are literally thousands of conditions that can cause epigenetic changes.

Nutrient deficiencies, for example exacerbated by soil depletion, can activate epigenetic changes that result in neurological issues from mood and behavioral disorders to cognitive dysfunction, and these problems are passed on to subsequent generations.12,13 Epigenetics helps explain why the skyrocketing sugar intake in our diets is causing obesity.14,15

Chemical exposures also have epigenetic consequences. Over the past century, we have been exposed to hundreds of thousands of chemicals that are new to human existence. Pesticides, insecticides, herbicides, and other chemicals all have the potential to modify epigenetic activity.16 Countless agents now ubiquitous in daily life, from air pollution to air fresheners and fabric softeners can negatively impact overall health.17,18

Societal changes

But it is not only diet, nutrition, and exposure to toxic chemicals that have changed in the past century. Another factor which has undergone radical transformation is the social milieu. The social sphere, which used to revolve around communities, has devolved to extended families, then to nuclear families, then single-parent families, and now, tragically at times, to homeless families or solitude.

It is no longer routine for people to go next door to be held by grandma, or move in with aunts and uncles when the going at home gets rough. In essence, safe shelter has disappeared. This lack of safety is compounded for survivors of childhood trauma, who often develop epigenetic abnormalities and thus pass the trauma on to their offspring.19

Intergenerational trauma

That’s right—PTSD can be inherited. A review paper by Rachel Yehuda and Amy Lehrner on intergenerational transmission of trauma and the role of epigenetic mechanisms states:

“There is now converging evidence supporting the idea that offspring are affected by parental trauma exposures occurring before their birth, and possibly even prior to their conception. On the simplest level, the concept of intergenerational trauma acknowledges that exposure to extremely adverse events impacts individuals to such a great extent that their offspring find themselves grappling with their parents’ post‐traumatic state.”20

PTSD is not only a psychological disorder, it triggers increasing dysregulation of an individual’s neurobiology.21

Other social factors also have an enormous impact on health and well-being. Social isolation is a major risk factor for depression.22 The chronic stresses of poverty, racism, homophobia, and misogyny not only make for a bad day, they act on our biochemical pathways impacting immune, hormonal, and neurological function.23

The long-term release of the stress hormone cortisol and of proteins called cytokines (which regulate the body’s immune system response) can cause even more damage. These biochemical messengers, in turn, can result in epigenetic changes that are passed on to future generations.24

We’re not born with a clean slate

Epigenetic transmission means that both physical and emotional traumas are cumulative over generations. Newborns are not born with a clean slate. And these alterations in epigenetics are manifesting in a tsunami that is destabilizing individuals’ core regulatory systems.

Increasingly, people respond as if they have continuous PTSD—their nervous and immune systems going haywire at both real and imagined threats, with all the downstream consequences evident in an increasingly sick population.

Which brings us back to PANS, which I have discussed in the past few articles.

I think we are witnessing an epidemic of autoimmune reactivity to multiple agents in the environment—like foods, viruses, bacteria, and mold. We are clearly seeing it with SARS-CoV-2 (COVID-19). When autoimmune reactivity results in neuroinflammation, it can result in cognitive dysfunction, PANS and a panoply of mental health disorders—for generations to come.

We need to become more cognizant of the cumulative stresses that result in combined mental and physical issues, and address them at their core.

Dr. Daniel Kinderlehrer is an internal medicine physician in Denver, Colorado, with a practice devoted to treating patients with tick-borne illness. He is the author of  Recovery From Lyme Disease: The Integrative Medicine Guide to the Diagnosis and Treatment of Tick-Borne Illness.

References

  1. https://pubmed.ncbi.nlm.nih.gov/24811552/
  2. https://www.healthline.com/health/obesity-facts#1.-More-than-one-third-of-adults-in-the-United-States-are-obese.
  3. https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a2.htm
  4. https://www.statista.com/statistics/676354/autism-rate-among-children-select-countries-worldwide/
  5. https://chadd.org/adhd-weekly/is-there-an-increase-in-adhd/
  6. https://www.immunology.org/news/report-reveals-the-rising-rates-autoimmune-conditions
  7. https://www.forbes.com/sites/williamhaseltine/2020/12/09/cancer-rates-are-on-the-rise-in-adolescents-and-young-adults-new-study-shows/?sh=5d56188c3b7b
  8. https://www.news-medical.net/health/Whats-Driving-the-Recent-Rise-in-Food-Allergies.aspx
  9. Tucci V, Moukaddam N. We are the hollow men: The worldwide epidemic of mental illness, psychiatric and behavioral emergencies, and its impact on patients and providers. J Emerg Trauma Shock. 2017;10(1):4-6. doi:10.4103/0974-2700.199517
  10. https://www.cdc.gov/nchs/products/databriefs/db379.htm
  11. https://webappa.cdc.gov/sasweb/ncipc/leadcause.html
  12. Liu J, Zhao SR, Reyes T. Neurological and Epigenetic Implications of Nutritional Deficiencies on Psychopathology: Conceptualization and Review of Evidence. Qi L, ed. Int J Mol Sci. 2015;16(8):18129-18148.
  13. https://www.scientificamerican.com/article/soil-depletion-and-nutrition-loss/
  14. https://www.tasteofhome.com/article/american-sugar-intake/
  15. Ling C, Rönn T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 2019;29(5):1028-1044.
  16. Collotta M1, Bertazzi PABollati V. Epigenetics and pesticides. Toxicology. 2013 May 10;307:35-41.
  17. https://www.sciencedirect.com/science/article/pii/S0360132316304334
  18. https://www.scientificamerican.com/article/greener-laundry/
  19. Matosin N, Cruceanu C, Binder EB. Preclinical and Clinical Evidence of DNA Methylation Changes in Response to Trauma and Chronic Stress. Chronic stress (Thousand Oaks). 2017;1:10.
  20. Yehuda R, Lehrner A. Intergenerational transmission of trauma effects: putative role of epigenetic mechanisms. World Psychiatry. 2018;17(3):243-257.
  21. McFarlane AC. The long-term costs of traumatic stress: intertwined physical and psychological consequences. World Psychiatry. 2010;9(1):3-10.
  22. Bhatti AB, Haq A ul. The Pathophysiology of Perceived Social Isolation: Effects on Health and Mortality. Muacevic A, Adler JR, eds. Cureus. 2017;9(1):e994.
  23. Song H et. al. Association of Stress-Related Disorders With Subsequent Autoimmune Disease. 2018;319(23):2388-2400.
  24. Notterman DA, Mitchell C. Epigenetics and Understanding the Impact of Social Determinants of Health. Pediatr Clinics North Am. 2015;62(5):1227-1240.

____________________

**Comment**

I’ve got news for you: vaccines are also stressors.  They can reactivate latent infections including but not limited to Lyme/MSIDS.  They can also be contaminated with retroviruses, viruses, cancer, parasites, metals, graphene oxide, polyethylene glycol (PEG) and ethylene alcohol, and other harmful nanoparticles.  And all gene-based vaccines such as the COVID jabs can be expected to cause blood clotting and bleeding disorders based on their molecular mechanisms of action. Further, the spike protein is a dangerous toxin causing untold damage.

Vaccines have been and are a source of destruction that is being put directly into bodies of millions worldwide. It is the “golden calf” no one wants to talk about, or is censored and bullied if they do, but is THE elephant in the room.

“A Tick Bite Turned Me Into the Bionic Woman – Entirely Preventable”

https://www.lymedisease.org/bradshaw-lyme-bionic-woman/

“A tick bite turned me into the bionic woman–entirely preventable”

The following public comments were provided by telephone to the federal Tick-Borne Disease Working Group on August 26.

My name is Meghan Bradshaw and I’m 28 years old. I’m here to share my story as a patient to demonstrate the magnitude of devastation that tick-borne diseases can cause.

My experience is unique, but it is similar to so many others in that the lack of accurate diagnostics led me to a situation that was entirely preventable.

Just a few years ago, I was an active, independent 20-something-year-old living in a bustling city. My career trajectory was moving quickly. But simultaneously I was battling with my health and had a steady, then very rapid decline.

Despite extensive lifestyle changes – eliminating alcohol, anti-inflammatory diet, and countless medication – I saw no changes, although I was doing what my doctors told me were “all the right things.”

Over the last few years, I have seen dozens of doctors across a spectrum of specialties at some of the most prominent medical institutions – Vanderbilt University and the world-renowned Cleveland Clinic. Not once were vector-borne illnesses ever considered to be the culprit.

Misdiagnosed, improperly treated

In 2017, I was improperly diagnosed with rheumatoid arthritis and followed the standard protocol of immunosuppressant therapeutics. This improper diagnosis is what ultimately opened the floodgates to allow the underlying tick-borne disease infections in my body to run rampant.

In October 2019 I started a series of surgeries:

  • Left knee synovectomy and meniscectomy
  • Bilateral total hip replacements
  • Bilateral total shoulder reverse arthroplasty
  • Proximal Interphalangeal Fusion on digits 2-5 Left hand
  • Last week, I had fusion of PIP digits 2-5 Right hand

Additionally, I am slated for

  • Bilateral knee, elbow and ankle replacements
  • Left wrist replacement

Also to note, nearly a dozen other joints have auto fused.

It’s one thing to list all these out, but to live it out daily, is an overwhelming burden- both functionally and financially.

I require assistance with virtually everything-bathing, toileting, grooming, dressing, feeding.

My fine motor skills are comparable to those of a toddler.

As a result of my immobility, I’ve had total muscular atrophy, losing over 60 pounds in less than a year, which is about 1/3 of my body composition, as I am 5’3”.

Physiological and emotional devastation

I want to stress not only the physiological and emotional devastation that lack of education in the medical community can cause, but also the extreme financial devastation that so many patients suffer from.

Over the last 24 months, my medical bills have totaled over $600,000 in extensive amounts of surgeries, hospital stays, therapeutics, and physical therapy. My family has spent nearly $200,000 out of pocket alone.

And to think that this is the result of inaccurate diagnostic tools and lack of education for a disease that impacts nearly half a million Americans every year.

For an illness that is twice as common as breast cancer, why are we not incorporating testing for tick-borne illnesses in our routine exams like a mammogram?

Tick safety education ought to be a part of our school health curriculum, just like sex ed. These are simple, cost-effective, preventative measures that we should be implementing to prevent potentially devastating outcomes.

I want to reiterate that I share my story not looking for sympathy but hoping to inspire change. There is not a shadow of a doubt in my mind that had there been better clinical education and accurate diagnostic tools available, I would not be in the position that I am today.

A tick bite turned me into the bionic woman, and this was entirely preventable.

Meghan Bradshaw lives in North Carolina. To hear more of her journey, listen to her recent interview on the Tick Boot Camp Podcast.

Click here to listen